Thirty-Day Readmissions after Transcatheter Aortic Valve Replacement in the United States: Insights from the Nationwide Readmissions Database

Circulation: Cardiovascular Interventions

Volumn 10, Issue 1, 2017, Pages

  Kolte, Dhaval ^a   Khera, Sahil ^b   Sardar, M Rizwan ^a,c   Gheewala, Neil ^d   Gupta, Tanush ^e   Chatterjee, Saurav ^f   Goldsweig, Andrew ^a   Aronow, Wilbert S ^b   Fonarow, Gregg C ^g   Bhatt, Deepak L ^h   Greenbaum, Adam B ^d   Gordon, Paul C ^a   Sharaf, Barry ^a   Abbott, J Dawn ^a  

^a BROWN UNIVERSITY   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

^c NORTHEAST OHIO MEDICAL UNIVERSITY   (United States)

^d HENRY FORD HOSPITAL   (United States)

^e ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^f TEMPLE UNIVERSITY HOSPITAL   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

aortic stenosis; costs and cost analysis; length of stay; readmission; rehospitalization; transcatheter aortic valve implantation; transcatheter aortic valve replacement

Indexed keywords

ACUTE KIDNEY FAILURE; AGED; ARTICLE; BLEEDING; CHRONIC KIDNEY FAILURE; CHRONIC LUNG DISEASE; COMORBIDITY; FEMALE; HEALTH CARE FACILITY; HEART ARRHYTHMIA; HEART FAILURE; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; ICD-9-CM; INCIDENCE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; SURVIVAL; TRANSCATHETER AORTIC VALVE IMPLANTATION; UNITED STATES; AORTIC VALVE STENOSIS; ECONOMICS; FACTUAL DATABASE; HOSPITAL COST; NURSING HOME; POSTOPERATIVE COMPLICATIONS; RISK FACTOR; TIME FACTOR; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AORTIC VALVE STENOSIS; COMORBIDITY; DATABASES, FACTUAL; FEMALE; HOSPITAL COSTS; HUMANS; LENGTH OF STAY; MALE; PATIENT DISCHARGE; PATIENT READMISSION; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; SKILLED NURSING FACILITIES; TIME FACTORS; TRANSCATHETER AORTIC VALVE REPLACEMENT; TREATMENT OUTCOME; UNITED STATES;

EID: 85010042742     PISSN: 19417640     EISSN: 19417632     Source Type: Journal    
DOI: 10.1161/CIRCINTERVENTIONS.116.004472     Document Type: Article

References (37)

1. Medicare.gov. 30-day unplanned readmission and death measures. 2016. https://www.medicare.gov/hospitalcompare/Data/30-day-measures.html. Accessed August 7, 2016.
2. Obama B. United States health care reform: progress to date and next steps. JAMA. 2016;316:525-532. doi: 10.1001/jama.2016.9797.
3. Jencks SF, Williams MV, Coleman EA. Rehospitalizations among patients in the Medicare fee-for-service program. N Engl J Med. 2009;360:1418-1428. doi: 10.1056/NEJMsa0803563.
4. Holmes DR Jr, Nishimura RA, Grover FL, Brindis RG, Carroll JD, Edwards FH, Peterson ED, Rumsfeld JS, Shahian DM, Thourani VH, Tuzcu EM, Vemulapalli S, Hewitt K, Michaels J, Fitzgerald S, Mack MJ; STS/ACC TVT Registry. Annual outcomes with transcatheter valve therapy: from the STS/ACC TVT Registry. J Am Coll Cardiol. 2015;66:2813-2823. doi: 10.1016/j.jacc.2015.10.021.
5. Hannan EL, Samadashvili Z, Jordan D, Sundt TM 3rd, Stamato NJ, Lahey SJ, Gold JP, Wechsler A, Ashraf MH, Ruiz C, Wilson S, Smith CR. Thirtyday readmissions after transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with severe aortic stenosis in New York State. Circ Cardiovasc Interv. 2015;8:e002744. doi: 10.1161/ CIRCINTERVENTIONS.115.002744.
6. Holmes DR Jr, Brennan JM, Rumsfeld JS, Dai D, O'Brien SM, Vemulapalli S, Edwards FH, Carroll J, Shahian D, Grover F, Tuzcu EM, Peterson ED, Brindis RG, Mack MJ; STS/ACC TVT Registry. Clinical outcomes at 1 year following transcatheter aortic valve replacement. JAMA. 2015;313:1019-1028. doi: 10.1001/jama.2015.1474.
7. Murugiah K, Wang Y, Desai NR, Nuti SV, Krumholz HM. Hospital variation in outcomes for transcatheter aortic valve replacement among Medicare beneficiaries, 2011 to 2013. J Am Coll Cardiol. 2015;66:2678-2679. doi: 10.1016/j.jacc.2015.10.008.
8. Nombela-Franco L, del Trigo M, Morrison-Polo G, Veiga G, Jimenez- Quevedo P, Abdul-Jawad Altisent O, Campelo-Parada F, Biagioni C, Puri R, DeLarochellière R, Dumont E, Doyle D, Paradis JM, Quirós A, Almeria C, Gonzalo N, Nuñez-Gil I, Salinas P, Mohammadi S, Escaned J, Fernández-Ortiz A, Macaya C, Rodés-Cabau J. Incidence, causes, and predictors of early (?30 days) and late unplanned hospital readmissions after transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2015;8:1748-1757. doi: 10.1016/j.jcin.2015.07.022.
9. US Agency for Healthcare Research and Quality. Overview of Key Readmission Measures and Methods. 2012. http://www.hcupus.ahrq.gov/ reports/methods/methods.jsp. Accessed August 7, 2016.
10. US Bureau of Labor Statistics, Division of Consumer Prices and Price Indexes. Consumer Price Index - All Urban Consumers. 2016. http://data. bls.gov/pdq/SurveyOutputServlet. Accessed May 20, 2016.
11. Curtis JP, Schreiner G, Wang Y, Chen J, Spertus JA, Rumsfeld JS, Brindis RG, Krumholz HM. All-cause readmission and repeat revascularization after percutaneous coronary intervention in a cohort of medicare patients. J Am Coll Cardiol. 2009;54:903-907. doi: 10.1016/j.jacc.2009.04.076.
12. Hannan EL, Zhong Y, Lahey SJ, Culliford AT, Gold JP, Smith CR, Higgins RS, Jordan D, Wechsler A. 30-day readmissions after coronary artery bypass graft surgery in New York State. JACC Cardiovasc Interv. 2011;4:569-576. doi: 10.1016/j.jcin.2011.01.010.
13. Wasfy JH, Rosenfield K, Zelevinsky K, Sakhuja R, Lovett A, Spertus JA, Wimmer NJ, Mauri L, Normand SL, Yeh RW. A prediction model to identify patients at high risk for 30-day readmission after percutaneous coronary intervention. Circ Cardiovasc Qual Outcomes. 2013;6:429-435. doi: 10.1161/CIRCOUTCOMES.111.000093.
14. Murugiah K, Wang Y, Dodson JA, Nuti SV, Dharmarajan K, Ranasinghe I, Cooper Z, Krumholz HM. Trends in hospitalizations among medicare survivors of aortic valve replacement in the United States from 1999 to 2010. Ann Thorac Surg. 2015;99:509-517. doi: 10.1016/j.athoracsur.2014.08.045.
15. Nguyen TC, Babaliaros VC, Razavi SA, Kilgo PD, Guyton RA, Devireddy CM, Shults CC, Mavromatis K, Kanitkar M, Block P, Lerakis S, Thourani VH. Impact of varying degrees of renal dysfunction on transcatheter and surgical aortic valve replacement. J Thorac Cardiovasc Surg. 2013;146:1399-1406, discussion 1406. doi: 10.1016/j.jtcvs.2013.07.065.
16. Suri RM, Gulack BC, Brennan JM, Thourani VH, Dai D, Zajarias A, Greason KL, Vassileva CM, Mathew V, Nkomo VT, Mack MJ, Rihal CS, Svensson LG, Nishimura RA, O'Gara PT, Holmes DR Jr. Outcomes of patients with severe chronic lung disease who are undergoing transcatheter aortic valve replacement. Ann Thorac Surg. 2015;100:2136-2145, discussion 2145. doi: 10.1016/j.athoracsur.2015.05.075.
17. Szerlip M, Kim RJ, Adeniyi T, Thourani V, Babaliaros V, Bavaria J, Herrmann HC, Anwaruddin S, Makkar R, Chakravarty T, Rovin J, Creighton D, Miller DC, Baio K, Walsh E, Katinic J, Letterer R, Trautman L, Herbert M, Farkas R, Rudolph J, Brown D, Holper EM, Mack M. The outcomes of transcatheter aortic valve replacement in a cohort of patients with end-stage renal disease. Catheter Cardiovasc Interv. 2016;87:1314-1321. doi: 10.1002/ccd.26347.
18. Dvir D, Waksman R, Barbash IM, Kodali SK, Svensson LG, Tuzcu EM, Xu K, Minha S, Alu MC, Szeto WY, Thourani VH, Makkar R, Kapadia S, Satler LF, Webb JG, Leon MB, Pichard AD. Outcomes of patients with chronic lung disease and severe aortic stenosis treated with transcatheter versus surgical aortic valve replacement or standard therapy: insights from the PARTNER trial (Placement of Aortic Transcatheter Valve). J Am Coll Cardiol. 2014;63:269-279. doi: 10.1016/j.jacc.2013.09.024.
19. Blackstone EH, Suri RM, Rajeswaran J, Babaliaros V, Douglas PS, Fearon WF, Miller DC, Hahn RT, Kapadia S, Kirtane AJ, Kodali SK, Mack M, Szeto WY, Thourani VH, Tuzcu EM, Williams MR, Akin JJ, Leon MB, Svensson LG. Propensity-matched comparisons of clinical outcomes after transapical or transfemoral transcatheter aortic valve replacement: a Placement of Aortic Transcatheter Valves (PARTNER)-I trial substudy. Circulation. 2015;131:1989-2000. doi: 10.1161/ CIRCULATIONAHA.114.012525.
20. Gada H, Kirtane AJ, Wang K, Lei Y, Magnuson E, Reynolds MR, Williams MR, Kodali S, Vahl TP, Arnold SV, Leon MB, Thourani V, Szeto WY, Cohen DJ; PARTNER Investigators. Temporal trends in quality of life outcomes after transapical transcatheter aortic valve replacement: a Placement of Aortic Transcatheter Valve (PARTNER) trial substudy. Circ Cardiovasc Qual Outcomes. 2015;8:338-346. doi: 10.1161/CIRCOUTCOMES.114.001335.
21. Mack MJ. Access for transcatheter aortic valve replacement: which is the preferred route? JACC Cardiovasc Interv. 2012;5:487-488. doi: 10.1016/j. jcin.2012.03.009.
22. Greenbaum AB, O'Neill WW, Paone G, Guerrero ME, Wyman JF, Cooper RL, Lederman RJ. Caval-aortic access to allow transcatheter aortic valve replacement in otherwise ineligible patients: initial human experience. J Am Coll Cardiol. 2014;63(25 pt A):2795-2804. doi: 10.1016/j.jacc.2014.04.015.
23. Mylotte D, Sudre A, Teiger E, Obadia JF, Lee M, Spence M, Khamis H, Al Nooryani A, Delhaye C, Amr G, Koussa M, Debry N, Piazza N, Modine T. Transcarotid transcatheter aortic valve replacement: feasibility and safety. JACC Cardiovasc Interv. 2016;9:472-480. doi: 10.1016/j. jcin.2015.11.045.
24. Généreux P, Kodali SK, Green P, Paradis JM, Daneault B, Rene G, Hueter I, Georges I, Kirtane A, Hahn RT, Smith C, Leon MB, Williams MR. Incidence and effect of acute kidney injury after transcatheter aortic valve replacement using the new valve academic research consortium criteria. Am J Cardiol. 2013;111:100-105. doi: 10.1016/j.amjcard.2012.08.057.
25. Arsalan M, Squiers JJ, Farkas R, Worley C, Herbert M, Stewart W, Brinkman WT, Ungchusri E, Brown DL, Mack MJ, Holper EM. Prognostic usefulness of acute kidney injury after transcatheter aortic valve replacement. Am J Cardiol. 2016;117:1327-1331. doi: 10.1016/j.amjcard.2016.01.037.
26. Lee DH, Buth KJ, Martin BJ, Yip AM, Hirsch GM. Frail patients are at increased risk for mortality and prolonged institutional care after cardiac surgery. Circulation. 2010;121:973-978. doi: 10.1161/ CIRCULATIONAHA.108.841437.
27. Schoenenberger AW, Stortecky S, Neumann S, Moser A, Jüni P, Carrel T, Huber C, Gandon M, Bischoff S, Schoenenberger CM, Stuck AE, Windecker S, Wenaweser P. Predictors of functional decline in elderly patients undergoing transcatheter aortic valve implantation (TAVI). Eur Heart J. 2013;34:684-692. doi: 10.1093/eurheartj/ehs304.
28. van der Boon RM, Nuis RJ, Benitez LM, Van Mieghem NM, Perez S, Cruz L, van Geuns RJ, Serruys PW, van Domburg RT, Dager AE, de Jaegere PP. Frequency, determinants and prognostic implications of infectious complications after transcatheter aortic valve implantation. Am J Cardiol. 2013;112:104-110. doi: 10.1016/j.amjcard.2013.02.061.
29. Tirado-Conte G, Freitas-Ferraz AB, Nombela-Franco L, Jimenez-Quevedo P, Biagioni C, Cuadrado A, Nuñez-Gil I, Salinas P, Gonzalo N, Ferrera C, Vivas D, Higueras J, Viana-Tejedor A, Perez-Vizcayno MJ, Vilacosta I, Escaned J, Fernandez-Ortiz A, Macaya C. Incidence, causes, and impact of in-hospital infections after transcatheter aortic valve implantation. Am J Cardiol. 2016;118:403-409. doi: 10.1016/j.amjcard.2016.05.012.
30. Himbert D, Vahanian A. Transcatheter aortic valve replacement for patients with heart failure. Heart Fail Clin. 2015;11:231-242. doi: 10.1016/j. hfc.2014.12.003.
31. Urena M, Webb JG, Eltchaninoff H, Muñoz-García AJ, Bouleti C, Tamburino C, Nombela-Franco L, Nietlispach F, Moris C, Ruel M, Dager AE, Serra V, Cheema AN, Amat-Santos IJ, de Brito FS, Lemos PA, Abizaid A, Sarmento-Leite R, Ribeiro HB, Dumont E, Barbanti M, Durand E, Alonso Briales JH, Himbert D, Vahanian A, Immè S, Garcia E, Maisano F, del Valle R, Benitez LM, García del Blanco B, Gutiérrez H, Perin MA, Siqueira D, Bernardi G, Philippon F, Rodés-Cabau J. Late cardiac death in patients undergoing transcatheter aortic valve replacement: incidence and predictors of advanced heart failure and sudden cardiac death. J Am Coll Cardiol. 2015;65:437-448. doi: 10.1016/j.jacc.2014.11.027.
32. Bradley EH, Curry L, Horwitz LI, Sipsma H, Wang Y, Walsh MN, Goldmann D, White N, Piña IL, Krumholz HM. Hospital strategies associated with 30-day readmission rates for patients with heart failure. Circ Cardiovasc Qual Outcomes. 2013;6:444-450. doi: 10.1161/ CIRCOUTCOMES.111.000101.
33. Chopard R, Teiger E, Meneveau N, Chocron S, Gilard M, Laskar M, Eltchaninoff H, Iung B, Leprince P, Chevreul K, Prat A, Lievre M, Leguerrier A, Donzeau-Gouge P, Fajadet J, Mouillet G, Schiele F; FRANCE-2 Investigators. Baseline characteristics and prognostic implications of pre-existing and new-onset atrial fibrillation after transcatheter aortic valve implantation: results from the FRANCE-2 Registry. JACC Cardiovasc Interv. 2015;8:1346-1355. doi: 10.1016/j.jcin.2015.06.010.
34. Biviano AB, Nazif T, Dizon J, Garan H, Fleitman J, Hassan D, Kapadia S, Babaliaros V, Xu K, Parvataneni R, Rodes-Cabau J, Szeto WY, Fearon WF, Dvir D, Dewey T, Williams M, Mack MJ, Webb JG, Miller DC, Smith CR, Leon MB, Kodali S. Atrial fibrillation is associated with increased mortality in patients undergoing transcatheter aortic valve replacement: insights from the Placement of Aortic Transcatheter Valve (PARTNER) Trial. Circ Cardiovasc Interv. 2016;9:e002766. doi: 10.1161/ CIRCINTERVENTIONS.115.002766.
35. Reynolds MR, Magnuson EA, Lei Y, Wang K, Vilain K, Li H, Walczak J, Pinto DS, Thourani VH, Svensson LG, Mack MJ, Miller DC, Satler LE, Bavaria J, Smith CR, Leon MB, Cohen DJ; PARTNER Investigators. Costeffectiveness of transcatheter aortic valve replacement compared with surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results of the PARTNER (Placement of Aortic Transcatheter Valves) trial (Cohort A). J Am Coll Cardiol. 2012;60:2683-2692. doi: 10.1016/j.jacc.2012.09.018.
36. Reynolds MR, Lei Y, Wang K, Chinnakondepalli K, Vilain KA, Magnuson EA, Galper BZ, Meduri CU, Arnold SV, Baron SJ, Reardon MJ, Adams DH, Popma JJ, Cohen DJ; CoreValve US High Risk Pivotal Trial Investigators. Cost-effectiveness of transcatheter aortic valve replacement with a self-expanding prosthesis versus surgical aortic valve replacement. J Am Coll Cardiol. 2016;67:29-38. doi: 10.1016/j.jacc.2015.10.046.
37. McCabe JM, Waldo SW, Kennedy KF, Yeh RW. Treatment and outcomes of acute myocardial infarction complicated by shock after public reporting policy changes in New York. JAMA Cardiol. 2016;1:648-654. doi: 10.1001/jamacardio.2016.1806.